Stanozolol as a trigger of drug-induced liver injury (DILI): A case report in a young patient

Authors

DOI:

https://doi.org/10.59093/27112330.163

Keywords:

stanozolol, anabolic steroids, cholestasis, drug-induced liver disease.

Abstract

Drug-induced liver injury (DILI) is a rare but clinically relevant condition, the diagnosis of which can be complex due to the variability of its manifestations and the need to exclude other causes. Anabolic-androgenic steroids, especially 17α-alkylated derivatives such as stanozolol, can cause dose-dependent hepatotoxicity, usually with a cholestatic pattern. We describe the case of a previously healthy 33-year-old woman who developed jaundice, pruritus, and choluria after the cosmetic use of injectable stanozolol. Laboratory studies showed direct hyperbilirubinemia and a moderate elevation of aminotransferases, while liver biopsy confirmed cytoplasmic cholestasis with portal inflammation. Despite meeting Hy's Law criteria, she did not develop with acute liver failure. Management was based on definitive discontinuation of the drug and symptomatic treatment with cholestyramine and ursodeoxycholic acid, with progressive clinical resolution. This case highlights the importance of suspecting DILI associated with anabolic steroids, making an early diagnosis, and educating the population about the risks of unsupervised use.

Downloads

Download data is not yet available.

Author Biographies

Adrianny Mahelis Arias-Choles, Clínica de la Costa

Médica, Residente de Medicina Interna, Universidad Simón Bolívar. Clínica de la Costa, Barranquilla, Colombia.

María Victoria Morales-Morales, Universidad del Sinú, Clínica de la Costa

Médica, Universidad del Sinú, Seccional Cartagena. Clínica de la Costa, Barranquilla, Colombia.

Eduardo Antonio Martínez-Bula, Universidad Simón Bolívar, Clínica de la Costa

Médico, Especialista en Medicina Interna, MSc en Salud Pública. Profesor, Universidad Simón Bolívar. Clínica de la Costa, Barranquilla, Colombia.

Marco Antonio Luján-Ramos, Universidad de Antioquia, Clínica de la Costa

Médico, Especialista en Medicina Interna, Especialista en Hepatología Clínica, Universidad de Antioquia. Clínica de la Costa, Barranquilla, Colombia.

References

Cho JH, Oh DS, Hong SH, Ko H, Lee NH, Park SE, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol 2017;91:4009-4015. https://doi.org/10.1007/s00204-017-2007-9.

Gómez-Rubio J, Bárcena-Atalaya AB, Ampuero-Herrojo J, Suárez E, Romero-Gómez M. Hepatotoxicidad inducida por estanozolol. RAPD online 2014;37:50-56.

Maddur H, Chalasani N. Idiosyncratic drug-induced liver injury: A clinical update. Curr Gastroenterol Rep 2011;13:65-71. https://doi.org/10.1007/s11894-010-0154-8.

Ortega-Alonso A, Andrade RJ. Hepatopatías de origen tóxico y farmacológico. Medicine 2016;12:545-552. https://doi.org/10.1016/j.med.2016.05.001.

Díaz-García JD, Córdova-Gallardo J, Torres-Viloria A, Estrada-Hernández R, Torre-Delgadillo A. Drug-induced liver injury secondary to anabolic steroid use. Rev Gastroenterol Mex 2020;85:92-94. https://doi.org/10.1016/j.rgmx.2019.01.003.

Cabrera-Rojas DL, Soto-Cardona J, Toro-Molina JL, Pérez-Cadavid JC, Marín-Zuluaga. Colestasis inducida por anabólicos: reporte de caso y revisión de la literatura. Hepatología. 2021;2:273-281. https://doi.org/10.52784/27112330.134.

LiverTox. Esteroides androgénicos. Bethesda (MD): Instituto Nacional de Diabetes y Enfermedades Digestivas y Renales; 2012. Actualizado el 30 de mayo de 2020. Disponible en http://www.livertox.nih.gov/.

Lo Re III V, Haynes K, Forde KA. Riesgo de insuficiencia hepática aguda en pacientes con lesión hepática inducida por fármacos: evaluación de la ley de Hy y un nuevo modelo pronóstico. Clin Gastroenterol Hepatol 2015;13:2360-2368. https://doi.org/10.1016/j.cgh.2015.06.020.

Stępień PM, Reczko K, Wieczorek A, Zarębska-Michaluk D, Pabjan P, Król T, Kryczka W. Severe intrahepatic cholestasis and liver failure after stanozolol usage - Case report and review of the literature. Clin Exp Hepatol 2015;1:30-33. https://doi.org/10.5114/ceh.2015.51376.

Ardila-Suárez OM, Oriz-Benjumea L, Arteta AA, Guevara-Casallas LG. Daño hepático inducido por medicamentos: relación entre el índice R y la histopatología. Rev Gastroenterol Mex 2023;88:19-27. https://doi.org/10.1016/j.rgmx.2021.03.008

Restrepo-Gutiérrez JC. DILI: un desafío. Hepatología 2020;1:97-98. https://doi.org/10.52784/27112330.118.

Published

2026-01-03

How to Cite

Arias-Choles, A. M., Morales-Morales, M. V., Martínez-Bula, E. A., & Luján-Ramos, M. A. (2026). Stanozolol as a trigger of drug-induced liver injury (DILI): A case report in a young patient. Hepatología, 7(1). https://doi.org/10.59093/27112330.163

Issue

Section

Case reports
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
Escanea para compartir
QR Code

Some similar items: